Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
biotech
boston blog main
boston
boston top stories
clinical trials
fda
national top stories
deals
detroit blog main
detroit top stories
san francisco blog main
aimmune therapeutics
akouos
aldehyde
aldeyra therapeutics
allergic conjunctivitis
allergy
anaphylaxis
andrew oxtoby
astellas pharmaceuticals
bempedoic acid
biopharma
boulder/denver blog main
boulder/denver top stories
brexanalone
california institute for biomedical research
cholesterol
clinical data
corticosteroids
daniel edelman
decibel therapeutics
depression
detroit
drugs
dry eye disease
duchenne
eosinophilic esophagitis
esperion therapeutics
What
fda
6
×
therapeutics
6
×
drug
approval
approved
medicine
medicines
phase
puts
second
therapy
treat
won
affects
agency
aimmune
aldeyra
allergy
americans
awarded
betting
billion
biopharma
brexanalone
cholesterol
closer
combo
data
date
deal
depression
developed
developing
disclosed
duchenne
esperion
esperion’s
eye
fighting
filing
Language
unset
Current search:
therapeutics
×
fda
×
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
